Wayne Philip Rothbaum

This inventor holds 66 USPTO granted patents and 49 published patent applications and 4 EPO patents, primarily in Cancer Treatment (CPC class A61K). Top assignees: Cjd LLC, Acerta Pharma B.v., Telios Pharma, Inc.. Active years: 1997-2026.

USPTO Granted Patents = 66 (Patent Applications = 49)

% Patents Active = 92.4

EPO Patents = 4 (Patent Applications = 19)

Average Co-Inventor Count = 3.7

ph-index = 21

Forward Citations = 1,559(Granted Patents)

Forward Citations (Not Self Cited) = 1,358(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Smithtown, NY (US) (1997)
New York, NY (US) (2011 - 2023)
Delray Beach, FL (US) (2018 - 2023)

Company Filing History:

Kartos Therapeutics, Inc.

6. 1 out of 834,411

Other

patents

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

Cancer Treatment

BTK Inhibitor

Therapeutic Combinations

Chronic Lymphocytic Leukemia

Myeloproliferative Neoplasms

Indolent Systemic Mastocytosis

Splenomegaly

Cord Management

PI3K Inhibitor

JAK-2 Inhibitor

BCL-2 Inhibitor

MEK Inhibitor

66 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697333 - Methods of treating splenomegaly (2026-08-04),

2. 12653827 - Methods of treating indolent systemic mastocytosis (2026-06-16),

3. 12414950 - Methods of treating indolent systemic mastocytosis (2025-09-16),

4. 12268681 - Methods of treating myeloproliferative neoplasms (2025-04-08),

5. 12263164 - Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor (2025-04-01),

6. 12115153 - Methods of treating cancer (2024-10-15),

7. 11771696 - Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor (2023-10-03),

8. 11654143 - Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor (2023-05-23),

9. 11642343 - Methods of treating splenomegaly (2023-05-09),

10. 11166951 - Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor (2021-11-09),

11. 11154554 - Therapeutic combinations of a MEK inhibitor and a BTK inhibitor (2021-10-26),

12. 11090302 - Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor (2021-08-17),

13. 10328080 - Therapeutic combination of PI3K inhibitor and a BTK inhibitor (2019-06-25),

14. 10272083 - Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor (2019-04-30),

15. D824244 - Strap for cord management (2018-07-31),

Title: Wayne Philip Rothbaum - Innovative Inventor from New York

Introduction: Wayne Philip Rothbaum is a renowned inventor based in New York, NY. His contributions to the field of innovation have been significant and impactful.

Latest Patents: Wayne Philip Rothbaum holds several patents in various industries, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his career, Wayne Philip Rothbaum has been recognized for his groundbreaking inventions that have revolutionized different sectors. His commitment to pushing the boundaries of technology is evident in his patent portfolio.

Collaborations: Wayne Philip Rothbaum has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work with diverse teams highlights his collaborative spirit and dedication to innovation.

Conclusion: Wayne Philip Rothbaum's passion for innovation, coupled with his exceptional talent for inventing, has solidified his reputation as a pioneering inventor in New York and beyond.